<unk>  is an antineoplastic agent and tyrosine kinase inhibitor that is FDA approved for the treatment of advanced renal cell carcinoma, advanced soft tissue sarcoma,. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include hypertension, hair color change, lymphocytopenia, musculoskeletal pain, headache and dyspnea.
Pazopanib hydrochloride
Toceranib
Semaxanib
Encorafenib
Regorafenib
Gilteritinib
Ranibizumab
Erdafitinib